EN DE
Watch Bon Natural Life Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Bon Natural Life Ltd (BON) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Bon Natural Life Ltd stock $2.52, price $1.11, upside +126.7%, quality 14 out of 100. Rating: strongly undervalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials US · Based in China · ISIN KYG144922047

BN Bon Natural Life Ltd logo Thin data Nov 9, 2026

Bon Natural Life Ltd

BON · US
Cheap, value-trap risk

The stock costs 56% less than our calculation considers fair.

Fair value $2.52 · Strongly undervalued
Low debt
Even on cautious assumptions the value is 49% above the price ($1.66).
Mixed vs. peers (4/10)
Quality 14/100
Weak Growth (revenue 5y +0.5 %/yr in USD)
Loss-making · -60.4% net margin (TTM)
Negative free cash flow
Narrow moat 13/100 · thin data
Thin data
⟳ Cyclical⚠ Dilution
Watch Bon Natural Life Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$3,328 $1.05 Fair Value $2.52 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.

How to read this chart

60‑month range $1.05 – $3,328 · fair‑value band $1.66 – $3.15 · the $1.11 price screens below the $2.52 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.

Follow Bon Natural Life in your weekly email

Every Wednesday you see whether Bon Natural Life is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East.

Show moreShow less

The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements.

It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited.

Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.

Stock analysis

Bon Natural Life Ltd (BON) currently trades at $1.11, while our model-based Fair Value estimate is $2.52, implying the stock looks roughly 56% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the data coverage at low.

Scenario range: $1.66 (bear) to $3.15 (bull), the price of $1.11 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 14/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Bon Natural Life Ltd reported revenue of $18.7M in FY2025 versus $25.5M in FY2021, a compound −7.5%/yr. Reported net income was −$2.0M in FY2025.

Key figures

Market cap $9.2M Micro · P/S ratio 0.49 · EPS (TTM) $−2.79 · Net margin −10.7% · Return on equity −21.8% · Return on assets (EBIT) 10.0% (5-year average) · Operating margin −82.2% · Revenue (TTM) $18.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 13 out of 100 (low confidence).

What moves the price

The share trades about 45% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at 127%, BON screens cheaper than that median.

Fair Value models

Bear $1.66 Fair Value $2.52 Bull $3.15
Price $1.11 · Upside +126.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $1.95 $2.96 $3.70 54
All 1 models by family
Asset-Based
NCAV (Graham) $1.95 $2.96 $3.70 54

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 14/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 6
How much profit the company makes from its sales and capital
Quality Growth 4
Are margins and returns getting better?
Cashflow 6
Do the profits arrive as real cash?
Financial strength 54
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 66
How calm the share price moves, does not count
Price momentum 23
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 3
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−21.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−14.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
19.0% (2020) → −8.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch BON, get fair value alerts →

Compare Bon Natural Life Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks

Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 14 · Bottom 25%
Fair Value upside +126.7% · Top 25%
Profitability
Return on assets −2.3% · Bottom 25%
Net margin (12 months) −60.4% · Bottom 25%
Operating margin (12 months) −82.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 1.9% · Below median
Balance sheet
Debt / equity 0.02× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 0.16× · Cheapest 25%
P/S (12 months) 0.49× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 0
FUTURE (revenue growth)10 · sector 67
PAST (return on equity)0 · sector 27
HEALTH (low debt)99 · sector 95
DIVIDEND (yield)0 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Nan Ya Plastics Corporation 1303 263.00 TWD 420.80 TWD +60% vs BON
Wanhua Chemical Group 600309 ¥72.65 ¥68.03 −6% vs BON
Linde plc LIN $515.25 $446.62 −13% vs BON
PPG Industries, Inc PPG $122.38 $77.68 −37% vs BON
DSM-Firmenich AG DSFIR CHF 100.50 CHF 57.70 −43% vs BON
The Sherwin-Williams Company SHW $344.10 $146.37 −57% vs BON
Givaudan SA GIVN CHF 4,054 CHF 1,554 −62% vs BON
EMS-CHEMIE HOLDING AG EMSN CHF 848.50 CHF 284.63 −66% vs BON
Ecolab Inc ECL $300.68 $96.56 −68% vs BON
Air Products and Chemicals, Inc APD $304.84 $75.33 −75% vs BON

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Bon Natural Life Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Bon Natural Life Ltd Fair Value". https://www.fairvalue-calculator.com/stock/BON

Frequently asked questions

Is Bon Natural Life Ltd (BON) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of $2.52 versus a price of $1.11, about +127% upside (undervalued).
What is the fair value of BON?
Our model-based fair value for Bon Natural Life Ltd is $2.52 (as of Nov 9, 2026), built from audited fundamentals. The current price: $1.11.
What is the quality score of BON?
Bon Natural Life Ltd has a Quality Score of 14/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bon Natural Life Ltd (BON)?
Our model-based price target is the fair value of $2.52 (as of Nov 9, 2026) from 1 valuation models. Cautious scenario $1.66, optimistic scenario $3.15. It is a calculation from audited fundamentals, not an analyst target.
What is the Bon Natural Life Ltd stock forecast for 2026?
Our models put fair value at $2.52, about +127% upside versus a price of $1.11 (undervalued). Cautious scenario $1.66, optimistic scenario $3.15. The calculation is refreshed regularly with new filings.
What is the revenue of Bon Natural Life Ltd (BON)?
Bon Natural Life Ltd reported trailing-twelve-month revenue of about $18.8M (latest available figure, as of Nov 9, 2026).
What is the intrinsic value of Bon Natural Life Ltd (BON)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bon Natural Life Ltd it is $2.52 per share (as of Nov 9, 2026), against a price of $1.11. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Bon Natural Life Ltd stock overvalued or undervalued in 2026?
As of Nov 9, 2026, BON trades below its calculated fair value: price $1.11, fair value $2.52, a gap of about +127% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BON?
No. The price is what the market pays today ($1.11); the fair value is what the company's own numbers justify ($2.52). For Bon Natural Life Ltd the two are $1.41 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bon Natural Life Ltd worth?
The market values Bon Natural Life Ltd at about $9.2M (market capitalisation, as of Nov 9, 2026). Per share that is $1.11; our models calculate a fair value of $2.52 per share.
What do the bullish and bearish scenarios say about BON?
Our models span a range for Bon Natural Life Ltd: cautious scenario $1.66, base $2.52, optimistic $3.15 per share (as of Nov 9, 2026, price $1.11). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Bon Natural Life Ltd (BON)?
Balance-sheet figures for Bon Natural Life Ltd (as of Nov 9, 2026): return on equity −21.8%, debt of 0.02 per unit of equity. They feed the Quality Score of 14/100, which measures business quality independently of the share price.
How far is BON from its 52-week high?
Bon Natural Life Ltd trades at $1.11, about 45% below its 52-week high of $2.00 and 6% above the low of $1.05 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $2.52 is for.
Which stocks are comparable to Bon Natural Life Ltd?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bon Natural Life Ltd stock attractive at the current price?
The data as of Nov 9, 2026: price $1.11, calculated fair value $2.52 (+127%), Quality Score 14/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BON calculated?
We run Bon Natural Life Ltd through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of $2.52 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Bon Natural Life Ltd currently trades 56% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bon Natural Life Ltd (BON)?
The closing price on Nov 6, 2026 was $1.11. Our model-based fair value is $2.52, about +127% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bon Natural Life Ltd right now?
The large discount to fair value meets weak quality (14/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($1.66). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($1.66 to $3.15) leaves room in how you read the outcome.

Key figures of Bon Natural Life Ltd

How large is the market capitalisation of Bon Natural Life Ltd (BON)?
The market capitalisation of Bon Natural Life Ltd is $9.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bon Natural Life Ltd (BON)?
The price-to-sales ratio of Bon Natural Life Ltd is 0.49 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bon Natural Life Ltd (BON)?
Earnings per share at Bon Natural Life Ltd are $−2.79. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Bon Natural Life Ltd (BON)?
The net margin of Bon Natural Life Ltd is −10.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bon Natural Life Ltd (BON)?
The return on equity (ROE) of Bon Natural Life Ltd is −21.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bon Natural Life Ltd (BON)?
On an EBIT basis the return on assets of Bon Natural Life Ltd is 10.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bon Natural Life Ltd (BON)?
The operating margin of Bon Natural Life Ltd is −82.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bon Natural Life Ltd (BON)?
Revenue at Bon Natural Life Ltd is growing +1.9% versus a year earlier (3y avg −14.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bon Natural Life Ltd (BON)?
Earnings per share at Bon Natural Life Ltd are growing −41.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Bon Natural Life Ltd (BON) generate?
The free cash flow of Bon Natural Life Ltd is −$4.2M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Bon Natural Life Ltd (BON) carry?
The net debt of Bon Natural Life Ltd is $6.1M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Bon Natural Life Ltd in the live analysis

One click puts Bon Natural Life Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.